Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1α effects on proteoglycan synthesis and content

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1020-1028

  Glansbeek, Harrie L ^a   Van Beuningen, Henk M ^a   Vitters, Elly L ^a   Morris, Elisabeth A ^b   Van der Kraan, Peter M ^a   Van den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; INTERLEUKIN 1ALPHA;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; AUTORADIOGRAPHY; CARTILAGE CELL; CELL DIFFERENTIATION; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; PROTEOGLYCAN SYNTHESIS; RECEPTOR UPREGULATION;

ANIMALS; AUTORADIOGRAPHY; BONE MORPHOGENETIC PROTEINS; CARTILAGE, ARTICULAR; INTERLEUKIN-1; KNEE JOINT; MALE; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030953118     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400605     Document Type: Article

References (37)

1. Saklatvala J: Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549, 1986
2. Van de Loo AAJ, van den Berg WB: Effects of murine recombinant IL-1 on synovial joints in mice: measurements of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 49:238-245, 1990
3. Pettipher ER, Higgs GA, Henderson B: Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A 83:8749-8753, 1986
4. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB: Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 38:164-172, 1995
5. Van de Loo FA, Arntz OJ, Otterness IG, van den Berg WB: Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 19:348-356, 1992
6. Van den Berg WB, Joosten LA, Helsen M, van de Loo FA: Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 95:237-243, 1994
7. Van Lent PLEM, van de Loo FAJ, Holthuysen AEM, van den Bersselaar LAM, Vermeer H, van den Berg WB: Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol 22: 2250-2258, 1995
8. Reddi AH: Cartilage morphogenesis: role of bone and cartilage morphogenetic proteins homeobox genes and extracellular matrix. Matrix Biol 14:599-606, 1995
9. Wozney JM: Bone morphogenetic proteins. Prog Growth Factor Res 1:267-280, 1989
10. Kingsley DM: The TGFβ superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994
11. Lin HY, Moustakas A: TGFβ receptors: structure and function. Cell Mol Biol 40:337-349, 1996
12. Morris E: Differential effects of TGFβ superfamily members on articular cartilage metabolism: stimulation by rhBMP-9 and rhBMP-2 and inhibition by TGFβ (abstract). Trans Orthop Res Soc 42:175, 1996
13. Duprez DM, Coltey M, Amthor H, Brickell PM, Tickle C: Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev Biol 174:448-452, 1996
14. Aikawa T, Shirasuna K, Iwamoto M, Watatani K, Nakamura T, Okura M, Yoshioka H, Matsuya T: Establishment of bone morphogenetic protein 2 responsive chondrogenic cell line. J Bone Miner Res 11:544-553, 1996
15. Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F: Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 6:1373-1385, 1991
16. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences. Ann Rheum Dis 53:593-600, 1994
17. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52:185-191, 1993
18. Van den Berg WB, Kruijsen MWM, van de Putte LBA, van Beusekom HJ, van der Sluis-van der Pol M, Zwarts WA: Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol 62:308-316, 1981
19. Van der Kraan PM, de Lange J, Vitters EL, van Beuningen HM, van Osch GJVM, van Lent PLEM, van den Berg WB: Analysis of changes in proteoglycan content in murine articular cartilage using image analysis. Osteoarthritis Cartilage 2:207-214, 1994
20. Van den Berg WB, Kruysen MWM, van de Putte LBA: The mouse patella assay: an easy method of quantitating articular cartilage chondrocyte function in vivo and in vitro. Rheumatol Int 1:165-169, 1982
21. Van Osch GJVM, van der Kraan PM, van den Berg WB: In vivo quantification of proteoglycan synthesis in articular cartilage of different topographical areas in the murine knee joint. J Orthop Res 11:492-499, 1993
22. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71:279-290, 1994
23. Luyten FP, Yu YM, Yanagishita M, Vukicevic S, Hammonds RG, Reddi AH: Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem 267:3691-3695, 1992
24. Flechtenmacher HK, Schmid TM, Davies SD, Mollenhauer J, Sampath TK, Kuettner KE, Thonar EJ, Aydelotte MB: Osteogenic protein 1 (OP-1) upregulates matrix synthesis by human articular chondrocytes cultured in the presence of serum and IL-1β (abstract). Trans Orthop Res Soc 41:381, 1995
25. Guerne P-A, Blanco F, Kaelin A, Desgeorges A, Lotz M: Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum 38:960-968, 1995
26. Yao J, Cole AA, Huch K, Kuettner KE: The effect of OP-1 on IL-1β induced gene expressions of matrix metalloproteinases and TIMP in human articular chondrocytes (abstract). Trans Orthop Res Soc 42:305, 1996
27. Lum ZP, Hakala BE, Mort JS, Recklies AD: Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. J Cell Physiol 166: 351-359, 1996
28. Chandrasekhar S, Harvey AK: Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 157: 1352-1359, 1988
29. Andrews HJ, Edwards TA, Cawston TE, Hazleman BL: Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro. Biochem Biophys Res Commun 162:144-150, 1989
30. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87:2220-2224, 1990
31. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167, 1992
32. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534, 1988
33. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Ozkaynak E, Oppermann H, Rueger DC: Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362, 1992
34. Hopkins SJ, Humphreys M, Jayson MIV: Cytokines in synovial fluid: the presence of biologically active and immunoreactive IL-1 Clin Exp Immunol 72:422-427, 1988
35. Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G: Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 51:731-734, 1992
36. Rooney M, Symons JA, Duff GW: Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10:217-219, 1990
37. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995